India · Delayed Price · Currency is INR Lincoln Pharmaceuticals Statistics
Total Valuation
BOM:531633 has a market cap or net worth of INR 10.17 billion. The enterprise value is 7.43 billion.
| Market Cap | 10.17B |
| Enterprise Value | 7.43B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 11, 2026 |
Share Statistics
BOM:531633 has 20.03 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 20.03M |
| Shares Outstanding | 20.03M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 48.07% |
| Owned by Institutions (%) | 2.10% |
| Float | 9.26M |
Valuation Ratios
The trailing PE ratio is 10.49.
| PE Ratio | 10.49 |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | 24.97 |
| P/OCF Ratio | 10.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.41, with an EV/FCF ratio of 18.25.
| EV / Earnings | 7.67 |
| EV / Sales | 1.03 |
| EV / EBITDA | 7.41 |
| EV / EBIT | 8.71 |
| EV / FCF | 18.25 |
Financial Position
The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.08 |
| Quick Ratio | 3.49 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.08 |
| Interest Coverage | 153.97 |
Financial Efficiency
Return on equity (ROE) is 12.69% and return on invested capital (ROIC) is 12.20%.
| Return on Equity (ROE) | 12.69% |
| Return on Assets (ROA) | 5.86% |
| Return on Invested Capital (ROIC) | 12.20% |
| Return on Capital Employed (ROCE) | 10.18% |
| Weighted Average Cost of Capital (WACC) | 7.15% |
| Revenue Per Employee | 5.34M |
| Profits Per Employee | 716,680 |
| Employee Count | 1,352 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 4.38 |
Taxes
In the past 12 months, BOM:531633 has paid 311.02 million in taxes.
| Income Tax | 311.02M |
| Effective Tax Rate | 24.30% |
Stock Price Statistics
The stock price has decreased by -3.46% in the last 52 weeks. The beta is 0.52, so BOM:531633's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -3.46% |
| 50-Day Moving Average | 573.18 |
| 200-Day Moving Average | 594.02 |
| Relative Strength Index (RSI) | 37.82 |
| Average Volume (20 Days) | 3,709 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:531633 had revenue of INR 7.22 billion and earned 968.95 million in profits. Earnings per share was 48.38.
| Revenue | 7.22B |
| Gross Profit | 3.66B |
| Operating Income | 853.01M |
| Pretax Income | 1.28B |
| Net Income | 968.95M |
| EBITDA | 1.00B |
| EBIT | 853.01M |
| Earnings Per Share (EPS) | 48.38 |
Balance Sheet
The company has 2.77 billion in cash and 34.22 million in debt, with a net cash position of 2.73 billion or 136.48 per share.
| Cash & Cash Equivalents | 2.77B |
| Total Debt | 34.22M |
| Net Cash | 2.73B |
| Net Cash Per Share | 136.48 |
| Equity (Book Value) | 8.12B |
| Book Value Per Share | 405.24 |
| Working Capital | 5.17B |
Cash Flow
In the last 12 months, operating cash flow was 937.93 million and capital expenditures -530.73 million, giving a free cash flow of 407.20 million.
| Operating Cash Flow | 937.93M |
| Capital Expenditures | -530.73M |
| Depreciation & Amortization | 150.18M |
| Net Borrowing | 33.55M |
| Free Cash Flow | 407.20M |
| FCF Per Share | 20.33 |
Margins
Gross margin is 50.74%, with operating and profit margins of 11.81% and 13.42%.
| Gross Margin | 50.74% |
| Operating Margin | 11.81% |
| Pretax Margin | 17.72% |
| Profit Margin | 13.42% |
| EBITDA Margin | 13.89% |
| EBIT Margin | 11.81% |
| FCF Margin | 5.64% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 0.35%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.74% |
| FCF Payout Ratio | 8.85% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.37% |
| Earnings Yield | 9.53% |
| FCF Yield | 4.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 19, 2009. It was a reverse split with a ratio of 0.2.
| Last Split Date | Mar 19, 2009 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |